Similar articles

• Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.

  Stassano P, Di Tommaso L, Monaco M, Iorio F, Pepino P, Spampinato N, Vosa C. Stassano P, et al. J Am Coll Cardiol. 2009 Nov 10;54(20):1862-8. doi: 10.1016/j.jacc.2009.07.032. J Am Coll Cardiol. 2009. PMID: 19892237 Clinical Trial.
• Anticoagulation after bioprosthetic aortic valve replacement.

  Nowell J, Jahangiri M. Nowell J, et al. J Thorac Cardiovasc Surg. 2010 Nov;140(5):1201-2; author reply 1202. doi: 10.1016/j.jtcvs.2010.06.058. J Thorac Cardiovasc Surg. 2010. PMID: 20951265 No abstract available.
• [Haemorrhagic and thrombo-embolic complications in patients with prosthetic valves--the under-appreciated problem with no safe solutions].

  Trzeciak P, Poloński L, Zembala M. Trzeciak P, et al. Kardiol Pol. 2006 Sep;64(9):1038-42. Kardiol Pol. 2006. PMID: 17054041 Review. Polish. No abstract available.
• eComment: Mechanical valve replacement in the elderly: does anticoagulation have benefit?

  Gunay R. Gunay R. Interact Cardiovasc Thorac Surg. 2009 Oct;9(4):581-2. doi: 10.1510/icvts.2008.193482B. Interact Cardiovasc Thorac Surg. 2009. PMID: 19773234 No abstract available.
• Therapeutic issues in prosthetic heart valve replacement.

  Verma P, Gambhir DS. Verma P, et al. Indian Heart J. 1997 Jul-Aug;49(4):373-81. Indian Heart J. 1997. PMID: 9358659 Review. No abstract available.